LYRICA is only approved for adults over 18.

WHAT TO EXPECT
WITH LYRICA

LYRICA is a daily medication that
should
be taken as prescribed by your
doctor.
Everyone is different, and
LYRICA may
take some time to
work for you.

LYRICA is only approved for adults over 18.

Doctor and patient discussing painful dpn treatment

GETTING THE MOST FROM LYRICA

Starting on LYRICA

There are things you can do when taking LYRICA (pregabalin) to get the most from your treatment. It’s important to work closely with your doctor and to keep track of how you are feeling and doing.

You may feel side effects before you start feeling better. If you are not feeling the pain relief you expect, there may be things your doctor can do to help.

GETTING TO YOUR RIGHT DOSE

Recommended LYRICA dosing

Start with 50 mg
3 times a day

(For a total of 150 mg/day)

May be increased
based on efficacy
& tolerability

Up to 100 mg
3 times a day

(For a total of 300 mg/day)

Work with your doctor to figure out the best dosage for you. Patients who do not experience sufficient diabetic nerve pain relief may be further increased up to 300 mg/day, based on efficacy and tolerability. Your doctor may continue to make adjustments according to your needs. If you have problems with kidney function, your doctor may prescribe a lower dose of LYRICA.

Man on pdpn treatment medication playing the trumpet

LYRICA is only approved for adults over 18.

DID YOU KNOW

Your doctor can adjust
your dose to help
you get the most
from treatment

WHAT TO EXPECT ROADMAP

WHEN TAKING LYRICA

Across all clinical studies, side effects were generally mild to moderate. Side effects can vary from person to person, so make sure to talk with your doctor about any side effects you may be experiencing.

Weeks

1-2 weeks

In clinical trials, some patients started feeling less diabetic nerve pain as early as the 1st week of treatment. For others, it took longer and individual results may vary.

It’s possible you may begin to feel side effects within the first week. The 2 most common side effects of LYRICA are dizziness and sleepiness. Across all clinical studies, dizziness occurred in 30% of LYRICA patients, compared with 8% of patients taking a placebo, and on average, lasted about 1 to 2 weeks. For some people, this went away over time. For others, these side effects lasted throughout the course of the studies.

If you do experience side effects, your doctor can adjust your dose or provide recommendations to help. Click here to learn more about sleepiness in clinical studies.

After the 1st week of treatment, your doctor may increase your dose based on the efficacy of LYRICA and how well you may tolerate it. Of course, your doctor will make adjustments based on how you’re feeling in regard to both pain relief and side effects. It’s not recommended that you take more than 300 mg of LYRICA per day for diabetic nerve pain.

3-4 weeks

After the first few weeks of taking LYRICA, follow up with your doctor and start discussing your complete treatment plan, and get any refills you may need.

This is the right time for you to discuss with your doctor how you are doing and any side effects you may feel.

Everyone is unique and may respond to LYRICA differently. LYRICA is available in multiple strengths. Your doctor can adjust your dose to help you get the most from treatment.

5 weeks+

After 1 to 2 months of taking LYRICA, be sure to continue to keep your doctor informed. This will enable you both to decide the best course of action to help you get the most from your treatment.

Sleepiness occurred in 23% of LYRICA patients, compared with 8% of patients taking a placebo, and on average, lasted about 4 to 6 weeks. For some people, these went away over time. For others, these side effects lasted throughout the course of the studies.

TALKING TO YOUR DOCTOR

Get helpful tips on how to
talk to your doctor about
diabetic nerve pain

Start Here

TERMS AND CONDITIONS

Offer Terms & Conditions:

By using the Co-Pay Savings Card, you acknowledge that you currently meet the eligibility criteria and will comply with the following terms and conditions:

This offer is not valid for prescriptions that are eligible to be reimbursed, in whole or in part, by Medicaid, Medicare, Tricare, or other federal or state healthcare programs (including any state prescription drug assistance programs) and the Government Health Insurance Plan available in Puerto Rico (formerly known as "La Reforma de Salud"). Savings are limited to $140 per month per prescription or the amount of your co-pay, whichever is less. (Maximum annual savings of $1680.) This offer is not valid when the entire cost of your prescription drug is eligible to be reimbursed by your private insurance plans or other health or pharmacy benefit programs. You must deduct the value received under this program from any reimbursement request submitted to your insurance plan, either directly by you or on your behalf. You must be 18 years of age or older to accept this offer. This offer is not valid where prohibited by law. This offer cannot be combined with any other rebate/coupon, free trial or similar offer for the specified prescription. The co-pay card will be accepted only at participating pharmacies. The co-pay card is not health insurance. Offer valid only in the U.S. and Puerto Rico. The co-pay card is limited to one per person during this offering period and is not transferable. Pfizer reserves the right to rescind, revoke or amend this offer without notice. No membership fee. Offer expires 12/31/2018.

For reimbursement when using a nonparticipating pharmacy/mail order:

Pay for prescription, and mail copy of original pharmacy receipt (cash register receipt NOT valid) with product name, date, and amount circled to: Co-Pay Savings Card, 2250 Perimeter Park Drive, Suite 300, Morrisville, NC 27560. Be sure to include a copy of the front of your activated Co-Pay Savings Card, your name and mailing address.

Mobile Terms & Conditions:

By agreeing to the terms of the Pfizer LSAVINGS mobile program (the "Program"), you consent to receive autodialed text messages on behalf of Pfizer. Consent is not a condition of purchase or use of any Pfizer product or service. The Program is valid with most major U.S. carriers. There is no fee payable to Pfizer to receive text messages; however, your carrier's message and data rates may apply. T-Mobile is NOT liable for delayed or undelivered messages.

Data obtained from you in connection with your registration for, and use of, the Program may include your phone number, related carrier information, and elements of pharmacy claim information, such as name, date of birth, and prescription information. You agree that such data may be used to administer the Program and to provide Program benefits such as savings offers, information about your prescription, including refill reminders and new prescription requests, as well as Program updates and alerts sent directly to your device.

For information on data collection and use, please read our Privacy Policy, which is incorporated by reference into these Terms.

Participants may receive up to 5 messages to enroll in the Program and recurring messages per month during the course of the Program. You may unsubscribe from the Program at any time by texting STOP to 597422. Doing so will only opt you out of the LSAVINGS mobile program; you will remain opted in to any other Pfizer Inc. text message program(s) to which you separately opted in. For help, text HELP to 597422. For questions about the Program, call 1-877-822-7855. You understand that you are responsible for notifying Pfizer immediately if you change your mobile telephone number. You agree to opt-out if the phone number that you previously provided is no longer associated with you. Pfizer reserves the right to rescind, revoke, or amend the Program without notice. You agree to review these Mobile Terms and Conditions periodically to ensure that you are aware of any changes. Your continued consent to receive text messages will indicate your acceptance of those changes.

E-mail Terms & Conditions:

By agreeing to the terms of LSAVINGS E-mail program (the "E-mail Program"), you consent to receive e-mail messages on behalf of Pfizer. Consent is not a condition of purchase or use of any Pfizer product or service.

Data obtained from you in connection with your registration for, and use of, the E-mail Program may include your e-mail address and elements of pharmacy claim information, such as name, date of birth, and prescription information. You agree that such data may be used to administer the E-mail Program and to provide E-mail Program benefits such as savings offers, information about your prescription, including refill reminders and new prescription requests, as well as E-mail Program updates and alerts sent directly to your e-mail address.

You may unsubscribe from the E-mail Program at any time by clicking on the unsubscribe link at the bottom of any E-mail Program e-mail. Please do not reply to E-mail Program e-mails as it is an unattended e-mail box. A link to contact Pfizer is at the bottom of every E-mail Program e-mail. Pfizer reserves the right to rescind, revoke, or amend the E-mail Program without notice.